Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
96
2024
2213
8.990
 Why?
Adrenal Cortex Hormones
27
2024
518
3.300
 Why?
Anti-Asthmatic Agents
27
2024
371
3.120
 Why?
Forced Expiratory Volume
19
2019
509
1.630
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
945
1.460
 Why?
Severity of Illness Index
20
2020
2722
1.030
 Why?
Administration, Inhalation
24
2024
661
0.940
 Why?
Anti-Inflammatory Agents
10
2016
468
0.930
 Why?
Lung Transplantation
10
2017
276
0.900
 Why?
Albuterol
5
2015
103
0.880
 Why?
Bronchodilator Agents
12
2016
243
0.850
 Why?
Budesonide
14
2016
88
0.830
 Why?
Nedocromil
11
2016
32
0.750
 Why?
Humans
126
2025
128418
0.730
 Why?
Self Report
3
2023
801
0.730
 Why?
Nasal Polyps
1
2021
57
0.730
 Why?
Endpoint Determination
2
2020
75
0.710
 Why?
Pharmacogenetics
2
2015
171
0.700
 Why?
Food Hypersensitivity
1
2022
173
0.650
 Why?
Sinusitis
1
2021
202
0.630
 Why?
Lung
7
2019
3743
0.630
 Why?
Virus Diseases
1
2021
209
0.610
 Why?
Physicians
2
2021
858
0.600
 Why?
Hospitalization
13
2020
2057
0.600
 Why?
Glucocorticoids
4
2022
571
0.600
 Why?
Remote Consultation
3
2025
46
0.590
 Why?
Symptom Assessment
1
2019
126
0.580
 Why?
Sleep Apnea, Obstructive
1
2021
238
0.580
 Why?
Oxygen Inhalation Therapy
4
2020
141
0.540
 Why?
Child
53
2022
20655
0.540
 Why?
Androstadienes
3
2012
106
0.530
 Why?
Disease Progression
14
2020
2602
0.530
 Why?
Emergency Service, Hospital
9
2013
1901
0.530
 Why?
Bone Density
2
2014
474
0.530
 Why?
Male
81
2024
62858
0.520
 Why?
Managed Care Programs
8
2008
133
0.510
 Why?
Precision Medicine
1
2020
384
0.510
 Why?
Adult
46
2024
35300
0.500
 Why?
Female
80
2024
68154
0.490
 Why?
Patient Reported Outcome Measures
1
2018
368
0.470
 Why?
Cost Savings
1
2015
78
0.470
 Why?
Practice Patterns, Physicians'
7
2020
1258
0.470
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
35
0.460
 Why?
Middle Aged
39
2024
30889
0.430
 Why?
Cost-Benefit Analysis
7
2022
568
0.430
 Why?
Peak Expiratory Flow Rate
2
2011
36
0.430
 Why?
Comorbidity
4
2021
1543
0.390
 Why?
Surveys and Questionnaires
14
2022
5362
0.370
 Why?
Adolescent
37
2019
20179
0.370
 Why?
Quality of Life
12
2023
2680
0.360
 Why?
Administration, Oral
6
2021
754
0.360
 Why?
Mentors
1
2012
178
0.350
 Why?
Medical Records Systems, Computerized
3
2008
93
0.350
 Why?
United States
23
2022
13830
0.350
 Why?
Respiratory Function Tests
10
2015
580
0.340
 Why?
Child, Preschool
31
2016
10384
0.330
 Why?
Medication Adherence
3
2023
560
0.330
 Why?
Faculty, Medical
1
2012
262
0.330
 Why?
Interprofessional Relations
3
2021
274
0.330
 Why?
Child Development
1
2014
452
0.320
 Why?
Spirometry
8
2020
251
0.320
 Why?
Treatment Outcome
15
2017
10152
0.310
 Why?
Aged
22
2022
21953
0.310
 Why?
Oxygen
3
2018
899
0.310
 Why?
Group Practice
1
2008
7
0.300
 Why?
Anti-Allergic Agents
2
2008
45
0.300
 Why?
Computer Simulation
1
2012
939
0.290
 Why?
Phenotype
5
2021
3044
0.280
 Why?
Dyspnea
3
2022
238
0.280
 Why?
Drug Utilization
4
2005
166
0.260
 Why?
Primary Health Care
5
2025
1670
0.260
 Why?
Follow-Up Studies
17
2017
4892
0.260
 Why?
Primary Graft Dysfunction
2
2017
29
0.260
 Why?
Quality Assurance, Health Care
1
2008
316
0.250
 Why?
Bronchiolitis Obliterans
3
2017
65
0.250
 Why?
Randomized Controlled Trials as Topic
7
2020
1356
0.250
 Why?
Gift Giving
1
2005
11
0.250
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.250
 Why?
Allergists
2
2022
12
0.240
 Why?
Respiratory Sounds
1
2006
120
0.240
 Why?
Genetic Testing
1
2008
428
0.240
 Why?
Delivery of Health Care
2
2021
895
0.240
 Why?
Cohort Studies
14
2013
5388
0.230
 Why?
Time Factors
10
2020
6482
0.220
 Why?
Antibodies, Monoclonal
2
2008
1355
0.220
 Why?
Leadership
2
2022
356
0.220
 Why?
Specialization
2
2025
145
0.220
 Why?
Natural Language Processing
1
2025
94
0.220
 Why?
Retrospective Studies
17
2022
14454
0.220
 Why?
Massachusetts
5
2016
158
0.220
 Why?
Medicine
1
2025
118
0.210
 Why?
Genetic Variation
1
2008
933
0.210
 Why?
Steroids
8
2011
147
0.210
 Why?
Recurrence
5
2013
996
0.210
 Why?
Rhinitis, Allergic, Perennial
1
2003
24
0.210
 Why?
Health Status
1
2008
755
0.210
 Why?
Predictive Value of Tests
9
2012
1935
0.200
 Why?
Young Adult
11
2019
12312
0.200
 Why?
Multicenter Studies as Topic
4
2018
285
0.200
 Why?
Prevalence
4
2022
2547
0.200
 Why?
Beclomethasone
1
2022
27
0.200
 Why?
Models, Theoretical
4
2007
542
0.190
 Why?
Desensitization, Immunologic
1
2022
89
0.190
 Why?
Academic Medical Centers
2
2022
476
0.180
 Why?
Biomarkers
3
2021
3880
0.180
 Why?
Tiotropium Bromide
2
2018
19
0.180
 Why?
Nebulizers and Vaporizers
2
2020
81
0.180
 Why?
Patient Preference
1
2023
185
0.180
 Why?
Social Class
2
2022
258
0.180
 Why?
Bronchoconstriction
3
2011
32
0.170
 Why?
Electronic Health Records
2
2025
974
0.170
 Why?
Pulmonologists
1
2020
15
0.170
 Why?
Churg-Strauss Syndrome
1
2020
26
0.170
 Why?
Granulomatosis with Polyangiitis
1
2020
42
0.170
 Why?
Capacity Building
1
2021
59
0.170
 Why?
Muscarinic Antagonists
1
2020
25
0.170
 Why?
Agammaglobulinemia
1
2020
33
0.170
 Why?
Physician-Patient Relations
2
2021
535
0.170
 Why?
Risk Factors
12
2018
9704
0.170
 Why?
Practice Guidelines as Topic
5
2020
1478
0.170
 Why?
Air Pollution, Indoor
2
2002
144
0.160
 Why?
Treatment Adherence and Compliance
1
2019
23
0.160
 Why?
Exercise Test
1
2022
613
0.150
 Why?
Receptors, IgE
2
2009
44
0.150
 Why?
Prognosis
8
2017
3772
0.150
 Why?
Allergens
1
2021
383
0.150
 Why?
Emergency Medical Services
2
2007
518
0.140
 Why?
Vitamin D
2
2012
380
0.140
 Why?
Fossil Fuels
1
1997
8
0.140
 Why?
Alemtuzumab
1
2017
15
0.140
 Why?
Photopheresis
1
2017
9
0.140
 Why?
Hypersensitivity
1
2020
249
0.140
 Why?
Biological Products
1
2020
197
0.140
 Why?
Drug Prescriptions
2
2011
248
0.140
 Why?
Respiration
1
2017
190
0.140
 Why?
Respiration Disorders
1
1997
72
0.130
 Why?
Aged, 80 and over
6
2019
7033
0.130
 Why?
Physicians, Primary Care
3
2021
229
0.130
 Why?
Drug Combinations
3
2012
323
0.130
 Why?
Immunomodulation
1
2017
89
0.130
 Why?
Socioeconomic Factors
4
2022
1212
0.130
 Why?
Statistics, Nonparametric
1
2017
418
0.130
 Why?
Drug Therapy, Combination
5
2020
1009
0.130
 Why?
Patient Admission
1
2018
182
0.130
 Why?
Scopolamine Derivatives
1
2015
7
0.130
 Why?
Breath Tests
2
2008
89
0.130
 Why?
Immunoglobulin G
1
2020
843
0.130
 Why?
Embolism, Fat
1
2015
11
0.130
 Why?
Tobacco Smoke Pollution
2
2010
229
0.120
 Why?
Transplants
1
2015
35
0.120
 Why?
Cholinergic Antagonists
1
2015
29
0.120
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
101
0.120
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
12
0.120
 Why?
Referral and Consultation
1
2021
727
0.120
 Why?
Genomics
2
2018
715
0.120
 Why?
Carcinoma, Bronchogenic
1
2015
19
0.120
 Why?
Postoperative Complications
2
2017
2485
0.120
 Why?
Longitudinal Studies
6
2017
2710
0.120
 Why?
Overweight
2
2011
524
0.120
 Why?
Telemedicine
1
2023
782
0.120
 Why?
Respiratory Tract Infections
2
2012
372
0.110
 Why?
Graft Rejection
2
2013
557
0.110
 Why?
Ambulatory Care Information Systems
2
2005
5
0.110
 Why?
Guideline Adherence
3
2020
521
0.110
 Why?
Prednisolone
1
2014
82
0.110
 Why?
Environmental Exposure
3
2006
461
0.110
 Why?
Risk
4
2015
853
0.110
 Why?
Education, Medical, Continuing
2
2005
121
0.110
 Why?
Quality Improvement
1
2022
1094
0.110
 Why?
Airway Obstruction
1
2015
149
0.110
 Why?
Forecasting
1
2015
358
0.110
 Why?
Transplantation
1
2013
25
0.100
 Why?
Bronchial Hyperreactivity
3
2010
104
0.100
 Why?
Office Visits
4
2011
84
0.100
 Why?
Insurance Claim Review
1
2013
64
0.100
 Why?
Medicare
2
2022
715
0.100
 Why?
Peer Group
2
2012
225
0.100
 Why?
Double-Blind Method
5
2010
1848
0.100
 Why?
Antibodies, Monoclonal, Humanized
2
2008
755
0.100
 Why?
Research
1
2015
411
0.100
 Why?
Growth
1
2012
58
0.100
 Why?
Cost of Illness
3
2003
277
0.100
 Why?
Costs and Cost Analysis
1
2013
199
0.100
 Why?
Methacholine Chloride
3
2008
51
0.100
 Why?
Cytomegalovirus Infections
2
2012
185
0.100
 Why?
Metered Dose Inhalers
1
2012
14
0.100
 Why?
Feedback
1
2012
159
0.100
 Why?
Drug Dosage Calculations
1
2011
20
0.100
 Why?
Mycoses
1
2012
69
0.100
 Why?
Logistic Models
5
2017
1974
0.100
 Why?
Antifungal Agents
1
2012
122
0.090
 Why?
Body Height
1
2012
192
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
12
0.090
 Why?
Multivariate Analysis
7
2017
1484
0.090
 Why?
Professional Role
1
2012
160
0.090
 Why?
Morbidity
2
2022
301
0.090
 Why?
Medication Errors
1
2012
95
0.090
 Why?
Obesity
3
2015
2858
0.090
 Why?
Epidemiologic Studies
1
2011
65
0.090
 Why?
Diagnostic Errors
1
2012
160
0.090
 Why?
Mycobacterium
1
2012
107
0.090
 Why?
Patient Readmission
1
2016
664
0.090
 Why?
Secondary Prevention
1
2012
219
0.090
 Why?
Pneumococcal Vaccines
1
2012
139
0.090
 Why?
Lung Diseases
1
2017
715
0.090
 Why?
Drug Resistance
1
2011
163
0.090
 Why?
Program Development
1
2012
360
0.090
 Why?
Vitamin D Deficiency
1
2012
176
0.090
 Why?
Probability
1
2011
305
0.090
 Why?
Ambulatory Care
2
2011
503
0.080
 Why?
Chi-Square Distribution
2
2017
511
0.080
 Why?
Decision Support Techniques
2
2012
396
0.080
 Why?
Bronchial Provocation Tests
2
2008
50
0.080
 Why?
Incidence
5
2020
2616
0.080
 Why?
Fluticasone
2
2008
90
0.080
 Why?
Immunoglobulin E
2
2008
329
0.080
 Why?
Algorithms
1
2017
1618
0.080
 Why?
Vital Capacity
4
2017
288
0.080
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
27
0.080
 Why?
Lectins, C-Type
1
2009
64
0.080
 Why?
Proportional Hazards Models
1
2012
1196
0.080
 Why?
Cross-Sectional Studies
6
2010
5039
0.080
 Why?
Health Services
2
2007
99
0.080
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1275
0.080
 Why?
Surgical Wound Infection
1
2012
277
0.080
 Why?
Pandemics
3
2022
1476
0.080
 Why?
Smoking
3
2017
1460
0.080
 Why?
Odds Ratio
4
2017
1023
0.080
 Why?
Kaplan-Meier Estimate
3
2016
853
0.080
 Why?
Medication Therapy Management
1
2010
74
0.080
 Why?
Acute Disease
1
2011
964
0.080
 Why?
Vitamin K Epoxide Reductases
1
2008
12
0.080
 Why?
Cytochrome P-450 CYP2C9
1
2008
20
0.080
 Why?
Eosinophil Cationic Protein
1
2008
10
0.080
 Why?
Mixed Function Oxygenases
1
2008
37
0.070
 Why?
Program Evaluation
1
2012
874
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
41
0.070
 Why?
Genetic Techniques
1
2008
63
0.070
 Why?
Genetic Predisposition to Disease
1
2016
2264
0.070
 Why?
Quality-Adjusted Life Years
2
2006
106
0.070
 Why?
Markov Chains
2
2006
116
0.070
 Why?
Trastuzumab
1
2008
100
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
23
0.070
 Why?
Cost Sharing
1
2008
14
0.070
 Why?
Adrenergic beta-Agonists
1
2008
129
0.070
 Why?
State Health Plans
1
2008
32
0.070
 Why?
Interviews as Topic
1
2011
715
0.070
 Why?
Smoking Cessation
1
2012
408
0.070
 Why?
Reimbursement Mechanisms
1
2008
84
0.070
 Why?
Chronic Disease
3
2017
1705
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
57
0.070
 Why?
Health Services Accessibility
2
2021
896
0.070
 Why?
Exercise Tolerance
2
2022
268
0.070
 Why?
Warfarin
1
2008
146
0.070
 Why?
Omalizumab
1
2007
50
0.070
 Why?
Factor Analysis, Statistical
1
2008
283
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
354
0.070
 Why?
Tomography, X-Ray Computed
1
2017
2523
0.070
 Why?
Databases, Factual
1
2012
1269
0.070
 Why?
Health Surveys
2
2006
492
0.070
 Why?
Antiviral Agents
1
2012
703
0.070
 Why?
Influenza Vaccines
1
2012
536
0.070
 Why?
Lung Diseases, Interstitial
1
2013
593
0.070
 Why?
Animals, Domestic
1
2006
14
0.070
 Why?
Receptor, ErbB-2
1
2008
325
0.060
 Why?
Biomedical Research
1
2012
635
0.060
 Why?
Eosinophils
1
2008
323
0.060
 Why?
Physicians, Family
2
2004
206
0.060
 Why?
Models, Biological
1
2012
1691
0.060
 Why?
Health Benefit Plans, Employee
1
2005
22
0.060
 Why?
Database Management Systems
1
2005
48
0.060
 Why?
Health Policy
1
2008
352
0.060
 Why?
Patients
1
2006
166
0.060
 Why?
Hip Fractures
1
2006
82
0.060
 Why?
Infant
3
2008
8914
0.060
 Why?
Insurance Coverage
1
2006
220
0.060
 Why?
Clinical Competence
1
2012
1013
0.060
 Why?
Patient Education as Topic
3
2005
737
0.060
 Why?
Body Mass Index
3
2015
2261
0.060
 Why?
Utilization Review
1
2004
36
0.060
 Why?
Mass Screening
1
2012
1147
0.060
 Why?
Gene Expression Profiling
1
2011
1688
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
563
0.050
 Why?
Anticoagulants
1
2008
613
0.050
 Why?
Medicaid
1
2008
433
0.050
 Why?
Vaccination
1
2012
1346
0.050
 Why?
Sex Factors
3
2016
1945
0.050
 Why?
Anti-Bacterial Agents
2
2004
1663
0.050
 Why?
Circadian Rhythm
1
2006
409
0.050
 Why?
Attitude to Health
1
2006
431
0.050
 Why?
Clinical Trials as Topic
2
2005
993
0.050
 Why?
Nitric Oxide
1
2008
882
0.050
 Why?
Parents
3
2006
1304
0.050
 Why?
Case Management
1
2003
64
0.050
 Why?
Choice Behavior
1
2004
164
0.050
 Why?
Puerto Rico
1
2022
52
0.050
 Why?
Symptom Flare Up
1
2022
38
0.050
 Why?
Lung Neoplasms
1
2015
2328
0.050
 Why?
Sputum
1
2004
302
0.050
 Why?
Academies and Institutes
1
2022
47
0.050
 Why?
Minority Groups
1
2003
251
0.050
 Why?
Health Services Research
1
2004
391
0.050
 Why?
Survival Rate
2
2016
1869
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
71
0.040
 Why?
Electronics
1
2021
73
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
90
0.040
 Why?
Sample Size
1
2020
115
0.040
 Why?
Efficiency
1
2021
92
0.040
 Why?
Health Care Reform
1
2021
100
0.040
 Why?
Schools, Medical
1
2021
131
0.040
 Why?
Risk Assessment
3
2020
3232
0.040
 Why?
Patient Selection
2
2020
663
0.040
 Why?
Pragmatic Clinical Trials as Topic
1
2020
62
0.040
 Why?
Patient Compliance
2
2016
560
0.040
 Why?
Language
1
2022
281
0.040
 Why?
Stress, Psychological
1
2007
1060
0.040
 Why?
Time
1
2019
75
0.040
 Why?
Cluster Analysis
2
2014
478
0.040
 Why?
Health Education
1
2002
333
0.040
 Why?
Quality of Health Care
1
2003
606
0.040
 Why?
Republic of Korea
1
2017
28
0.040
 Why?
Poland
1
2017
33
0.040
 Why?
Bronchitis, Chronic
1
2017
19
0.040
 Why?
Cooperative Behavior
1
2021
432
0.040
 Why?
Sensitivity and Specificity
3
2013
1815
0.040
 Why?
Patient-Centered Care
1
2003
501
0.040
 Why?
Nitrogen Dioxide
1
1997
33
0.040
 Why?
Long-Term Care
1
2018
89
0.030
 Why?
Geography
1
2018
186
0.030
 Why?
Pediatrics
1
2005
1046
0.030
 Why?
Self Concept
1
2019
242
0.030
 Why?
Antineoplastic Agents
1
2008
2051
0.030
 Why?
Monitoring, Physiologic
2
2012
266
0.030
 Why?
Aftercare
1
2019
206
0.030
 Why?
Netherlands
1
2016
77
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
135
0.030
 Why?
Perception
1
2019
338
0.030
 Why?
Feasibility Studies
1
2020
860
0.030
 Why?
Formoterol Fumarate
1
2015
7
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
15
0.030
 Why?
Ethanolamines
1
2015
18
0.030
 Why?
Salmeterol Xinafoate
1
2015
41
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
44
0.030
 Why?
Immunosuppressive Agents
2
2015
680
0.030
 Why?
Treatment Failure
1
2016
339
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
1936
0.030
 Why?
Education
1
2015
100
0.030
 Why?
Postoperative Period
1
2016
324
0.030
 Why?
Self Efficacy
1
2019
374
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2062
0.030
 Why?
Age Factors
3
2008
3103
0.030
 Why?
Fatal Outcome
1
2015
300
0.030
 Why?
Pilot Projects
1
2020
1564
0.030
 Why?
Patient Acceptance of Health Care
1
2021
758
0.030
 Why?
Biopsy
2
2013
1081
0.030
 Why?
Combined Modality Therapy
1
2017
1204
0.030
 Why?
Gene Expression
1
2018
1456
0.030
 Why?
Telephone
2
2005
168
0.030
 Why?
Echinocandins
1
2012
7
0.030
 Why?
Lipopeptides
1
2012
13
0.030
 Why?
Tissue Donors
1
2015
388
0.030
 Why?
Amphotericin B
1
2012
29
0.030
 Why?
Aspergillosis
1
2012
20
0.030
 Why?
Intention to Treat Analysis
1
2012
69
0.030
 Why?
Candidiasis
1
2012
53
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
280
0.020
 Why?
Transplantation, Homologous
1
2013
396
0.020
 Why?
Hypoxia
1
2019
1036
0.020
 Why?
Mycobacterium avium Complex
1
2012
86
0.020
 Why?
Age Distribution
2
2003
371
0.020
 Why?
Cromolyn Sodium
2
2001
11
0.020
 Why?
Leukotriene Antagonists
1
2011
43
0.020
 Why?
Triazoles
1
2012
147
0.020
 Why?
Self Care
2
2005
368
0.020
 Why?
Functional Residual Capacity
1
2010
8
0.020
 Why?
Colorado
1
2021
4375
0.020
 Why?
Reference Values
1
2012
776
0.020
 Why?
Costa Rica
1
2010
16
0.020
 Why?
Principal Component Analysis
1
2011
183
0.020
 Why?
Health
1
2010
73
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
204
0.020
 Why?
Inhalation
1
2010
28
0.020
 Why?
Genome-Wide Association Study
1
2016
1336
0.020
 Why?
Environment
1
2011
342
0.020
 Why?
Observation
1
2008
51
0.020
 Why?
Sex Ratio
1
2008
13
0.020
 Why?
Prospective Studies
2
2012
7036
0.020
 Why?
Least-Squares Analysis
1
2008
72
0.020
 Why?
Models, Econometric
1
2008
33
0.020
 Why?
Health Services Administration
1
2007
8
0.020
 Why?
Treatment Refusal
1
2008
87
0.020
 Why?
Social Isolation
1
2007
60
0.020
 Why?
Intelligence
1
2007
129
0.020
 Why?
Puberty
1
2008
142
0.020
 Why?
Body Weight
1
2011
928
0.020
 Why?
Child Behavior Disorders
1
2007
135
0.020
 Why?
Exercise
1
2016
1929
0.010
 Why?
Insurance, Health
1
2007
267
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1046
0.010
 Why?
Animals
1
2006
34479
0.010
 Why?
Genotype
1
2009
1828
0.010
 Why?
Bronchoconstrictor Agents
1
2003
16
0.010
 Why?
Health Status Indicators
1
2004
166
0.010
 Why?
Organizational Innovation
1
2004
138
0.010
 Why?
Case-Control Studies
1
2010
3328
0.010
 Why?
Systems Integration
1
2003
41
0.010
 Why?
Computer Systems
1
2003
44
0.010
 Why?
Motor Activity
1
2007
668
0.010
 Why?
Child Welfare
1
2004
211
0.010
 Why?
Histamine H1 Antagonists
1
2002
29
0.010
 Why?
Self Disclosure
1
2002
62
0.010
 Why?
Drug Administration Schedule
1
2004
751
0.010
 Why?
Administration, Intranasal
1
2002
82
0.010
 Why?
Confidence Intervals
1
2002
316
0.010
 Why?
Nurse's Role
1
2003
139
0.010
 Why?
Regression Analysis
1
2003
978
0.010
 Why?
Point-of-Care Systems
1
2003
146
0.010
 Why?
Health Care Surveys
1
2002
555
0.010
 Why?
Sex Distribution
1
2001
358
0.010
 Why?
Caregivers
1
2007
810
0.010
 Why?
Patient Satisfaction
1
2004
641
0.010
 Why?
Decision Support Systems, Clinical
1
2003
206
0.010
 Why?
Disease Management
1
2003
587
0.010
 Why?
Linear Models
1
2002
813
0.010
 Why?
Bronchoscopy
1
2000
207
0.010
 Why?
Internet
1
2003
617
0.010
 Why?
Pregnancy
1
2010
6357
0.010
 Why?
Survival Analysis
1
2000
1263
0.010
 Why?
Infant, Newborn
1
2004
5687
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (19) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)